New Delhi: Glenmark Pharmaceuticals has received the final nod from the US health regulator for generic oral contraceptive norgestimate ethinyl estradiol tablets. In a BSE filing, the company said Glenmark Pharmaceuticals USA has been granted final approval by the US Food & Drug Administration (USFDA) for "norgestimate and ethinyl estradiol tablets USP, 0.18 mg/0.025 mg, […]
The post Glenmark’s US arm receives US FDA approval for contraceptive tablets appeared first on Firstpost.